Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Neutropenia 1Neoplasms 1Fever 1Exanthema 1Colorectal Neoplasms 1

Interventions

pegfilgrastim 13Filgrastim 8Cyclophosphamide 3liposomal amphotericin B 2eflapegrastim 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Levofloxacin 2Idarubicin 2Fluconazole 2Etoposide 2Docetaxel 2Cytarabine 2Ciprofloxacin 2Cefepime 2Caspofungin 2Amsacrine 2pegylated granulocyte colony-stimulating factor 1ceftobiprole medocaril 1Vancomycin 1Tretinoin 1Thioguanine 1Radiotherapy 1Psychiatric Rehabilitation 1MYL-1401H 1Lithium Carbonate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Daunorubicin 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neutropenia × Anti-Bacterial Agents × Clear all
NCT03768869 2021-04-27

Fever and Neutropenia in Pediatric Oncology Patients

University of Colorado, Denver

Phase 3 Withdrawn

Fever, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡